AC
IBB icon

Alley Company’s iShares Biotechnology ETF IBB Stock Holding History

Alley Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-27,513
Closed -$2.65M – 79
2016
Q3 		$2.65M Buy
27,513
+378
+1% +$36K 1.18% 38
2016
Q2 		$2.33M Buy
27,135
+252
+0.9% +$22.6K 1.06% 45
2016
Q1 		$2.34M Buy
26,883
+723
+3% +$64.7K 1.12% 39
2015
Q4 		$2.95M Buy
26,160
+576
+2% +$62.5K 1.44% 31
2015
Q3 		$2.59M Buy
25,584
+852
+3% +$102K 1.33% 35
2015
Q2 		$3.04M Sell
24,732
-897
-3% -$107K 1.5% 31
2015
Q1 		$2.93M Sell
25,629
-519
-2% -$57.2K 1.44% 32
2014
Q4 		$2.64M Buy
26,148
+1,803
+7% +$175K 1.36% 32
2014
Q3 		$2.22M Sell
24,345
-114
-0.5% -$10K 1.6% 29
2014
Q2 		$2.1M Sell
24,459
-738
-3% -$58.1K 1.49% 30
2014
Q1 		$1.99M Buy
25,197
+774
+3% +$64.5K 1.4% 37
2013
Q4 		$1.85M Buy
24,423
+2,280
+10% +$162K 1.34% 36
2013
Q3 		$1.55M Buy
22,143
+1,119
+5% +$73.3K 1.24% 42
2013
Q2 		$1.22M Buy
+21,024
New +$1.22M 1.02% 49

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alley Company's IBB Position: Q4 2016 in Review

Alley Company sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 27,513 shares — an estimated $2.65M sold.

Alley Company first reported a position in IBB in Q2 2013 and held it in 14 quarters. The position peaked at $3.04M in Q2 2015. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • Alley Company reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
  • Alley Company sold 27,513 iShares Biotechnology ETF shares in Q4 2016, an estimated $2.65M.
  • Alley Company first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 14 quarters.
  • Alley Company's iShares Biotechnology ETF position peaked at $3.04M in Q2 2015.
  • 522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Alley Company's 13F filing for Q4 2016, filed 2 Feb 2017.